加减丹栀逍遥散通过吞噬作用改善干眼症小鼠角膜损伤
本研究探讨加减丹栀逍遥散(MDXP)治疗干眼症(DED)小鼠的作用机制。采用慢性疼痛刺激联合苯扎氯铵滴眼在干燥箱中诱导DED模型28天,随后MDXP不同剂量灌胃14天。结果显示MDXP可增加体重、降低体温、延长泪膜破裂时间、促进泪液分泌、修复角膜损伤并降低炎症因子及fcγR介导吞噬通路相关蛋白表达,机制可能通过fcγR介导的吞噬通路。
要点
- MDXP可改善DED小鼠角膜损伤及泪液分泌。
- MDXP降低TNF-α、IL-1β及CDC42、ARPC2、ACTR3表达。
- 机制可能通过fcγR介导的吞噬通路。
核心结论
- MDXP可缓解紧张焦虑、抑制凋亡、减少吞噬作用、降低促炎因子表达、修复角膜损伤并改善DED小鼠症状。
研究设计与样本
- 小鼠DED模型采用慢性疼痛刺激(夹尾)联合苯扎氯铵滴眼在干燥箱中诱导28天,建模后MDXP组不同剂量灌胃14天。
主要发现
- MDXP增加体重、降低体温、延长泪膜破裂时间、促进泪液分泌、修复角膜损伤。
- MDXP降低水平和垂直评分,提高开臂次数百分比和开臂时间百分比。
- MDXP降低TNF-α、IL-1β及CDC42、ARPC2、ACTR3表达水平。
- MDXP降低人角膜内皮细胞(HCECs)、小鼠单核巨噬细胞(RAW264.7)和人髓系白血病单核细胞(THP-1)中TNF-α和IL-1β表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Modified Danzhi Xiaoyao Powder (MDXP) is a traditional Chinese medicine formula remedy for treating Dry Eye Disease (DED). It showed the function of dispersing stagnated liver Qi for relieving Qi stagnation and clearing heat, which can be effective in treating conditions such as Dry Eye Disease (DED) and irregular menstruation due to liver depression and fire transformation. AIM OF THE STUDY: This study investigated the mechanism of the effect of MDXP in mice with DED. MATERIALS AND METHODS: A DED model was induced in mice using chronic painful stimulation (tail clamping) in combination with Benzalkonium Chloride Solution drops administered in a dry box for 28 days. After modeling, the MDXP groups were given Chinese medicine with different dosages by gavage for 14 days. The following parameters were recorded in each group: body mass, anal temperature, tear secretion, tear film rupture time, and corneal fluorescein staining. Behavioral changes were evaluated by elevating cross-maze and open-field experiments. The levels of inflammatory factors serum tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), fcγR-mediated phagocytosis pathway cell division control protein 42 homolog (CDC42), actin-related protein 2/3 complex subunit 2 (ARPC2), and actin-related protein 3 (ACTR3) were measured by using Enzyme-linked immunoassay (ELISA), immunohistochemical staining, and real-time fluorescent qualitative polymerase chain reaction (RT-qPCR). RESULTS: MDXP increased body mass and lowered body temperature, prolonged tear film break-up time, promoted tear secretion, repaired corneal damage, decreased horizontal and vertical scores, elevated percentage of open arm times and boom opening time percentage, and reduced the expression levels of inflammatory factors of TNF-α, IL-1β and pathway-related proteins CDC42, ARPC2, and ACTR3 in mice. MDXP also reduced the expression levels of inflammatory factors of TNF-α and IL-1β in human corneal endothelial cells (HCECs), mouse mononuclear macrophage cells (RAW264.7), and human myeloid leukemia mononuclear cells (THP-1). CONCLUSIONS: MDXP can relieve tension and anxiety, inhibit apoptosis, reduce phagocytosis, reduce the expression of pro-inflammatory factors, repair corneal damage, and improve the symptoms in DED mice. The mechanism of action may be through the fcγR-mediated phagocytosis pathway.
引用
- Liu P, Jiang P, Yu Y, et al. Modified Danzhi Xiaoyao Powder (MDXP) improves the corneal damage in dry eye disease (DED) mice through phagocytosis. J Ethnopharmacol. 2023. PMID: 38070838. doi:10.1016/j.jep.2023.117544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。